Company intelligence / Profile preview

Aces Diagnostics

Arizona, United Statesacesdiagnostics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Aces Diagnostics has developed LYMESEEK™, a novel blood-based diagnostic test for Lyme disease that uses a multi-antigen approach combined with AI/machine learning. The test demonstrates an initial accuracy rate of 89% and an overall accuracy rate of 91% across all phases of Lyme disease. It is designed to detect infection within the first 14 days—significantly earlier than current standard tests, which are only about 28–50% accurate in early-stage cases. This enables timely diagnosis and treatment, potentially reducing chronic illness from missed or delayed diagnoses.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic testDevice
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

LymeSeek

Pre-clinical

Indications: Lyme disease

Partnerships

Tulane University Innovation Institute collaboration/supportFocus On Lyme Foundation involvement/support

Beyond the preview

Go deeper on Aces Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aces Diagnostics.

Explore the full profile